(S)-tert-butyl 6-hydroxy-1,4-oxazepane-4-carboxylate, 95.0%, 100mg

2-Chlorobenzoic acid, >=98%, for synthesis, 250 g, plastic packaging.

6-Chloro-8-(trifluoromethyl)chroman-4-one, 95.0%, 100mg

N-(3-(Trifluoromethyl)benzyl)ethanamine, 95.0%, 25g

(S)-(+)-6-Methyl-1-octanol>98.0%(GC)5mL

7-Bromo-3,4-dihydrobenzo[f][1,4]oxazepin-5(2H)-one, 98%, 1g

Ethyl 5-phenyloxazole-2-carboxylate, 95.0%, 250mg

1-(2-Amino-4-hydroxy-3-methylphenyl)ethanone, 95%, 250mg

(S)-tert-butyl 3-(((4-bromophenyl)sulfonyl)oxy)piperidine-1-carboxylate, 97%, 100mg

(R)-2-(Diphenylphosphino)-1-phenylethanamine, 95%, 100mg

4-[4-(dimethylamino)benzoyl]-8-methyl-1-oxa-4,8-diazaspiro[4.5]decane-3-carboxylic acid, 95.0%, 1g

Test sieve Ø 200 mm, 0.71 mm, 1 Piece(s)

(R)-2-((tert-Butoxycarbonyl)amino)-3-hydroxy-3-methylbutanoic acid, 95.0%, 100mg